These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 22747752)
1. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection. Schunter M; Chu H; Hayes TL; McConnell D; Crawford SS; Luciw PA; Bengmark S; Asmuth DM; Brown J; Bevins CL; Shacklett BL; Critchfield JW BMC Complement Altern Med; 2012 Jun; 12():84. PubMed ID: 22747752 [TBL] [Abstract][Full Text] [Related]
2. Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection. Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M Front Immunol; 2021; 12():688886. PubMed ID: 34135912 [TBL] [Abstract][Full Text] [Related]
3. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial. González-Hernández LA; Jave-Suarez LF; Fafutis-Morris M; Montes-Salcedo KE; Valle-Gutierrez LG; Campos-Loza AE; Enciso-Gómez LF; Andrade-Villanueva JF Nutr J; 2012 Oct; 11():90. PubMed ID: 23101545 [TBL] [Abstract][Full Text] [Related]
4. Probiotic effects on immunity and microbiome in HIV-1 discordant patients. Blázquez-Bondia C; Parera M; Català-Moll F; Casadellà M; Elizalde-Torrent A; Aguiló M; Espadaler-Mazo J; Santos JR; Paredes R; Noguera-Julian M Front Immunol; 2022; 13():1066036. PubMed ID: 36569851 [TBL] [Abstract][Full Text] [Related]
5. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Cunningham-Rundles S; Ahrné S; Johann-Liang R; Abuav R; Dunn-Navarra AM; Grassey C; Bengmark S; Cervia JS Nutrients; 2011 Dec; 3(12):1042-70. PubMed ID: 22292110 [TBL] [Abstract][Full Text] [Related]
6. The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation. Chevalier MF; Petitjean G; Dunyach-Rémy C; Didier C; Girard PM; Manea ME; Campa P; Meyer L; Rouzioux C; Lavigne JP; Barré-Sinoussi F; Scott-Algara D; Weiss L PLoS Pathog; 2013; 9(6):e1003453. PubMed ID: 23818854 [TBL] [Abstract][Full Text] [Related]
7. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion. Gascon RL; Narváez AB; Zhang R; Kahn JO; Hecht FM; Herndier BG; McGrath MS J Acquir Immune Defic Syndr; 2002 Jun; 30(2):146-53. PubMed ID: 12045676 [TBL] [Abstract][Full Text] [Related]
8. Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study. Valiathan R; Miguez MJ; Patel B; Arheart KL; Asthana D PLoS One; 2014; 9(5):e97698. PubMed ID: 24842313 [TBL] [Abstract][Full Text] [Related]
9. Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials. Kim CJ; Walmsley SL; Raboud JM; Kovacs C; Coburn B; Rousseau R; Reinhard R; Rosenes R; Kaul R HIV Clin Trials; 2016 Jul; 17(4):147-57. PubMed ID: 27267710 [TBL] [Abstract][Full Text] [Related]
10. Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans. Eller MA; Blom KG; Gonzalez VD; Eller LA; Naluyima P; Laeyendecker O; Quinn TC; Kiwanuka N; Serwadda D; Sewankambo NK; Tasseneetrithep B; Wawer MJ; Gray RH; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK PLoS One; 2011 Apr; 6(4):e18779. PubMed ID: 21526194 [TBL] [Abstract][Full Text] [Related]
11. HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment. Rueda CM; Velilla PA; Chougnet CA; Montoya CJ; Rugeles MT PLoS One; 2012; 7(1):e30307. PubMed ID: 22276176 [TBL] [Abstract][Full Text] [Related]
12. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. Sereti I; Estes JD; Thompson WL; Morcock DR; Fischl MA; Croughs T; Beq S; Lafaye de Micheaux S; Yao MD; Ober A; Wilson EM; Natarajan V; Imamichi H; Boulassel MR; Lederman MM; Routy JP PLoS Pathog; 2014 Jan; 10(1):e1003890. PubMed ID: 24497828 [TBL] [Abstract][Full Text] [Related]
13. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy. d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625 [TBL] [Abstract][Full Text] [Related]
14. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals. Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967 [TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. Ellis CL; Ma ZM; Mann SK; Li CS; Wu J; Knight TH; Yotter T; Hayes TL; Maniar AH; Troia-Cancio PV; Overman HA; Torok NJ; Albanese A; Rutledge JC; Miller CJ; Pollard RB; Asmuth DM J Acquir Immune Defic Syndr; 2011 Aug; 57(5):363-70. PubMed ID: 21436711 [TBL] [Abstract][Full Text] [Related]
16. A pilot study of brisk walking in sedentary combination antiretroviral treatement (cART)- treated patients: benefit on soluble and cell inflammatory markers. Bonato M; Galli L; Passeri L; Longo V; Pavei G; Bossolasco S; Bertocchi C; Cernuschi M; Balconi G; Merati G; Lazzarin A; La Torre A; Cinque P BMC Infect Dis; 2017 Jan; 17(1):61. PubMed ID: 28077069 [TBL] [Abstract][Full Text] [Related]
17. Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection. Page EE; Greathead L; Metcalf R; Clark SA; Hart M; Fuchs D; Pantelidis P; Gotch F; Pozniak A; Nelson M; Boasso A; Gazzard B; Kelleher P J Acquir Immune Defic Syndr; 2014 Nov; 67(3):227-35. PubMed ID: 25314246 [TBL] [Abstract][Full Text] [Related]
18. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects. Serrano-Villar S; Vázquez-Castellanos JF; Vallejo A; Latorre A; Sainz T; Ferrando-Martínez S; Rojo D; Martínez-Botas J; Del Romero J; Madrid N; Leal M; Mosele JI; Motilva MJ; Barbas C; Ferrer M; Moya A; Moreno S; Gosalbes MJ; Estrada V Mucosal Immunol; 2017 Sep; 10(5):1279-1293. PubMed ID: 28000678 [TBL] [Abstract][Full Text] [Related]
19. Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217. Macatangay BJ; Yang M; Sun X; Morton J; De Gruttola V; Little S; Hogan C; Rinaldo CR; J Acquir Immune Defic Syndr; 2017 May; 75(1):137-141. PubMed ID: 28198712 [TBL] [Abstract][Full Text] [Related]
20. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. Dyrhol-Riise AM; Voltersvik P; Olofsson J; Asjö B AIDS; 1999 Dec; 13(17):2365-76. PubMed ID: 10597778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]